EN
HI
Summary
As of 11 Sep, 2026, Bal Pharma stock price is ₹111.33. During the trading session, the stock has moved between an intraday low of ₹104.13 and an intraday high of ₹114.95. Over the last 52 weeks, Bal Pharma has traded between ₹60.00 and ₹124.60.
The stock has recorded a trading volume of 2,44,938 shares,. Its Average Traded Price (ATP) is ₹111.48, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 89 @ ₹111.33.
Bal Pharma has an upper circuit limit of ₹127.45 and a lower circuit limit of ₹84.97. The total value traded stands at ₹2.73 CR, and the delivery percentage for the day is 38.91%.
The stock is currently traded with a market lot size of 1. Bal Pharma also offers a dividend yield of 1.13%.
Bal Pharma Share Price Chart
Bal Pharma Share Key Metrics
Volume
2.45 L
Market Cap
169.10 CR
LTQ@LTP
89@111.33
ATP
111.48
Var Margin
23.36 %
Circuit Range
84.97-127.45
Delivery %
38.91 %
Value
2.73 CR
ASM/GSM
No
Market Lot
1
Bal Pharma Fundamentals
P/E Ratio
23.49
P/B Ratio
2.03
Div. Yield
1.13
Sector P/E
41.56
Sector P/B
3.6
Sec. Div. Yield
0.5
Bal Pharma Resistance and Support
Pivot 111.95
Resistance
First Resistance
118.85
Second Resistance
131.5
Third Resistance
138.4
Support
First Support
99.3
Second Support
92.4
Third Support
79.75
Bal Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 105.6 | 111.33 | 4.83% | 114.95 | 104.13 |
| Thu Sep 10 2026 | 120 | 106.2 | -7.20% | 124.59 | 105.05 |
| Wed Sep 09 2026 | 95.09 | 114.44 | 20.00% | 114.44 | 95.09 |
Bal Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Dividend |
| 2025-02-13 | Quarterly Results & Fund Raising |
| 2024-08-12 | Quarterly Results |
Bal Pharma News
Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Allotment
Bal Pharma Ltd's Board approved the allotment of 1 million convertible warrants to its promoter, Mr. Shailesh Siroya, at Rs. 84 per warrant. This preferential allotment aggregates to Rs. 8.40 crore, with 25% upfront payment received.
Sep 07 2026 18:16:08
Bal Pharma Ltd - 524824 - Intimation Of Record Date For Final Dividend
Bal Pharma has fixed September 17, 2026, as the record date for its final dividend for FY 2025-26. Eligible shareholders will receive ₹1.20 per equity share, with payment commencing on or after September 24, 2026.
Aug 27 2026 14:29:16
Read More
Bal Pharma Management
| Name | Position |
|---|---|
| Shailesh Siroya | Managing Director |
| Himesh Virupakshaya | Whole Time Director |
Bal Pharma FAQs
The Buying Price of Bal Pharma share is 111.33 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bal Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bal Pharma shares is 23.49. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bal Pharma shares is 2.03. Useful to assess the stock's value relative to its book value.
To assess Bal Pharma’s valuation compare Sector P/E, P/B which are 41.56 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bal Pharma is 169.10 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bal Pharma share price is 124.60 & 60.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bal Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BALPHARMA
